We constructed a valid, innovative, and reliable 11-GRGs prognostic model (PGK1, SDC1, NUP43, NT5E, IL13RA1, GCLC, CACNA1H, P4HA1, TSTA3, MXI1, and STC1) to predict BC patient outcomes. This evidence concerns the gene MXI1 and breast cancer.